A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
Janssen Research & Development, LLC
Pfizer
Fate Therapeutics
Opna Bio LLC
Incyte Corporation
Celgene
University of Wisconsin, Madison
AbbVie
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center